Evotec and Yale University form Open Innovation Alliance

摘要

German small molecule drug developer Evotec has joined forces with Yale University in the US to develop new discovery approaches to diseases of high unmet medical need by combining the biology performed at Yale with Evotec's drug discovery infrastructure.